Schneider Downs Wealth Management Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$258K Buy
+215
New +$220K 0.02% 149
2026
Q1
Sell
-207
Closed -$223K 160
2025
Q4
$223K Buy
+207
New +$198K 0.03% 145
2024
Q4
Sell
-239
Closed -$212K 143
2024
Q3
$212K Sell
239
-2
-0.8% -$1.8K 0.04% 133
2024
Q2
$218K Sell
241
-64
-21% -$51.2K 0.05% 122
2024
Q1
$237K Sell
305
-119
-28% -$84.7K 0.05% 119
2023
Q4
$247K Buy
+424
New +$247K 0.06% 99
2022
Q4
Sell
-760
Closed -$246K 136
2022
Q3
$246K Sell
760
-19
-2% -$6.02K 0.07% 107
2022
Q2
$253K Sell
779
-30
-4% -$9.01K 0.07% 113
2022
Q1
$232K Sell
809
-482
-37% -$124K 0.06% 134
2021
Q4
$357K Sell
1,291
-185
-13% -$46.9K 0.09% 103
2021
Q3
$341K Buy
1,476
+472
+47% +$116K 0.09% 96
2021
Q2
$230K Buy
+1,004
New +$202K 0.06% 127

Other funds holding LLY

Schneider Downs Wealth Management Advisors's LLY Position: Q2 2026 in Review

Schneider Downs Wealth Management Advisors opened a new position in Eli Lilly (LLY) in Q2 2026: 215 shares worth $258K. The stake represents 0.02% of the portfolio and ranks #149 among its holdings. This is a return to the name: Schneider Downs Wealth Management Advisors previously reported a position in LLY as recently as Q4 2025.

Schneider Downs Wealth Management Advisors first reported a position in LLY in Q2 2021 and has held it in 12 quarters since. The position peaked at $357K in Q4 2021. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Schneider Downs Wealth Management Advisors held 215 shares of Eli Lilly worth $258K as of Q2 2026.
  • Eli Lilly was a new Schneider Downs Wealth Management Advisors position in Q2 2026.
  • Eli Lilly made up 0.02% of Schneider Downs Wealth Management Advisors's portfolio in Q2 2026, its #149 holding.
  • Schneider Downs Wealth Management Advisors first reported a position in Eli Lilly in Q2 2021 and has held it in 12 quarters since.
  • Schneider Downs Wealth Management Advisors's Eli Lilly position peaked at $357K in Q4 2021.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Schneider Downs Wealth Management Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.